1. Home
  2. Knowledge Base
  3. References
  4. Repeated mu-opioid exposure induces a novel form of the hyperalgesic priming model for transition to chronic pain.

Repeated mu-opioid exposure induces a novel form of the hyperalgesic priming model for transition to chronic pain.

Araldi D, Ferrari L, Levine J (2015) Repeated mu-opioid exposure induces a novel form of the hyperalgesic priming model for transition to chronic pain. J Neurosci 35:12502-12517. doi: 10.1523/JNEUROSCI.1673-15.2015

Summary: Repeated administration of mu-opioid receptor agonists can lead to persistent mechanical hyperalgesia. One current hypothesis is that a form of hyperalgesic priming is triggered by the repeated activation of these receptors. Classic hyperalgesic priming is associated with signaling via protein kinase Cε (PKε), which is mediated by isolectin-B4+ (IB4) nociceptors. In this work the authors eliminated the IB4+ nociceptors with a 3.2 μg intrathecal injection of recombinant IB4-SAP (Cat. #IT-10). The authors found that hyperalgesic priming induced through the use of DAMGO was dependent on protein kinase A activation rather than activation of PKε. This work demonstrates a novel model for hyperalgesic priming transitioning to chronic pain.

Related Products: IB4-SAP (Cat. #IT-10)